Publications
- Pazopanib for Metastatic Renal Cell Carcinoma: A Registry-based Analysis of 426 Patients2018 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University
- Complete remission of metastatic malignant melanoma treated with nivolumab, complicated with pulmonary toxicity2018 | Faculty of Medicine in Hradec Králové
- Pembrolizumab in pretreated patient2018 | Faculty of Medicine in Hradec Králové
- Current possibilities of immunotherapy in the treatment of malignant melanoma2018 | Faculty of Medicine in Hradec Králové
- Possible Pitfalls of Ipilimumab Therapy in Malignant Melanoma - a Case Report2015 | Faculty of Medicine in Hradec Králové
- Program of Palliative Cancer Care – Our Experience2013 | Faculty of Medicine in Hradec Králové
- Prevention, diagnosis and treatment of cancer-associated thromboembolism2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
Loading network view...